Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir
| Status: | Completed |
|---|---|
| Conditions: | Diabetes, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/27/2017 |
| Start Date: | March 2009 |
| End Date: | September 2009 |
Insulin Detemir Co-administered With Liraglutide: An Open Label Trial to Assess Insulin Detemir and Liraglutide Pharmacokinetics and Pharmacodynamics Following Liraglutide Therapy in Subjects With Type 2 Diabetes
This trial is conducted in the United States. The aim of this clinical trial is to
investigate whether chronic liraglutide administration affects the mode of action
(pharmacokinetics) of insulin detemir
investigate whether chronic liraglutide administration affects the mode of action
(pharmacokinetics) of insulin detemir
Inclusion Criteria:
- Diagnosed with type 2 diabetes
- BMI less than 45.0 kg/m2
- Insulin naive
- Currently treated with Oral Anti-Diabetic drugs (OADs) and metformin with a HbA1c
between 7.0 and 9.5% or currently treated with metformin only with a HbA1c between
7.0 and 10.0%
Exclusion Criteria:
- Any clinically significant disease other than type 2 diabetes
- Currently using daily insulin
- Thiazolidinione use or other injectable diabetes medications within the last 3 months
We found this trial at
1
site
Click here to add this to my saved trials
